Torleva XR 500 Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Levetiracetam (500mg)
Overview Torleva XR 500 Tablet
Epileptic seizures are managed with the anticonvulsant medication, Torleva XR 500mg tablets. This medication, administered alone or in conjunction with other therapies, helps control seizures by suppressing abnormal brain activity. Consistent daily dosing at the same time, regardless of food intake, maximizes effectiveness. Dosage is individualized based on patient response and overall health; your physician will determine the appropriate regimen. Long-term use is typical, and continuation as prescribed is crucial to prevent seizure recurrence. Discontinuing or missing doses increases seizure risk. Headache, irritability, drowsiness, behavioral shifts (including aggression), and reduced appetite are common, often subsiding after the initial adjustment period. While many side effects are mild, some may require medical attention. Suicidal ideation has been reported in rare cases; report any worsening mood changes immediately to your doctor. Prior to commencing treatment, inform your physician of any kidney disease, depressive symptoms, suicidal tendencies, pregnancy, pregnancy plans, or breastfeeding. Regular blood tests to monitor kidney function may be recommended during treatment.
Uses of Torleva XR 500 Tablet
Managing Epileptic Seizures
Major Benefits of Torleva XR 500 Tablet:
Follow your doctor's instructions or consult the product label for proper administration. Torleva XR 500 Tablets can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Torleva XR 500 Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Headache
- Decreased appetite
- Behavioral changes
- Aggressive behavior
- Irritation
- Agitation
- Nasal congestion (stuffy nose)
- Infection
- Convulsion
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Tremors
- Vertigo
- Lethargy
How to use Torleva XR 500 Tablet:
Follow your doctor's instructions or the package leaflet for proper administration. Torleva XR 500 Tablets can be ingested with or without food; however, consistent daily timing is recommended.
How Torleva XR 500 Tablet works:
Levetiracetam extended-release 500 mg tablets are used to control epileptic seizures. Their mechanism involves binding to synaptic vesicle protein 2A (SV2A) receptors on neurons, thereby reducing excessive neuronal firing and preventing the propagation of seizure-inducing electrical impulses in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Combining Torleva XR 500 Tablets with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
Extended-release Torleva 500 mg tablets present a low risk to pregnant individuals and their fetuses, according to the majority of research.
Breast feedingSAFE IF PRESCRIBED
Extended-release Torleva 500 mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant. Observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, blurred vision, or dizziness after taking Torleva XR 500 mg tablets, as these side effects can impair alertness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Torleva XR 500mg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Torleva XR 500 Tablets in patients with liver impairment is likely safe. Available evidence indicates dose modification may be unnecessary for most; however, patients with severe hepatic dysfunction might benefit from a reduced dosage. Physician consultation is recommended.
What if you forget to take Torleva XR 500 Tablet :
Should you forget a dose of Torleva XR 500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Torleva XR 500 Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrrolidinone-Acetamide Hybrid |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |
| Actions | AED: A protein ligand bound to synaptic vesicle 2 |






